| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.001 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.002 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |